Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia

• Status: Unknown status
• Trial end date: 2011-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Amantadine as add-on therapy to antipsychotics may improve schizophrenia positive, negative and cognitive symptoms.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Amantadine; Antipsychotic Agents

Criteria

Inclusion Criteria:

• Under antipsychotics with residual symptoms

Exclusion Criteria:

• Pregnancy

• Lactation